 <h1>Sivextro Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>tedizolid</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about tedizolid. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Sivextro.</p><h2>In Summary</h2><p><b>More frequent side effects include:</b> diarrhea.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to tedizolid: oral tablet</i></p><p>Other dosage forms:</p><ul><li>intravenous powder for solution</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, tedizolid (the active ingredient contained in Sivextro) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking tedizolid:</p><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision</li>
<li>chest tightness</li>
<li>diarrhea</li>
<li>dizziness</li>
<li>fast, slow, pounding, or irregular heartbeat or pulse</li>
<li>fever</li>
<li>headache</li>
<li>hives or welts, itching, or skin rash</li>
<li>hoarseness</li>
<li>irritation</li>
<li>itching of the vagina or genitals</li>
<li>joint pain, stiffness, or swelling</li>
<li>nervousness</li>
<li>pale skin</li>
<li>pounding in the ears</li>
<li>redness of the skin</li>
<li>severe stomach cramps and pain</li>
<li>sore mouth or tongue</li>
<li>stomach tenderness</li>
<li>swelling of the eyelids, face, lips, hands, or feet</li>
<li>thick, white vaginal discharge with mild or no odor</li>
<li>trouble breathing or swallowing</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>watery or severe diarrhea, which may also be bloody</li>
<li>white patches in the mouth or on the tongue</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Black, tarry stools</li>
<li>blood in the urine or stools</li>
<li>chills</li>
<li>cough</li>
<li>lower back or side pain</li>
<li>painful or difficult urination</li>
<li>pinpoint red spots on the skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of tedizolid may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Nausea</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>double vision</li>
<li>feeling of warmth</li>
<li>feeling that you cannot keep your eyes open</li>
<li>increased sensitivity of the eyes to light</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>seeing floating spots before the eyes</li>
<li>sore neck, shoulders, or back</li>
<li>sore, tired, burning, or itching eyes</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
<li>vomiting</li>
<li>watery or dry eyes</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tedizolid: intravenous powder for injection, oral tablet</i></p><h3>General</h3><p>The most common side effects were nausea, headache, diarrhea, vomiting, and dizziness.  Median time to onset was 5 days.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Clostridioides difficile colitis, oral candidiasis, abdominal pain, constipation, abdominal discomfort, dry mouth, dyspepsia, upper abdominal pain, flatulence, gastroesophageal reflux disease, hematochezia, retching<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness, peripheral neuropathy</p>
<p><b>Uncommon</b> (0.1% to 1%): Somnolence, dysgeusia, tremor, hypoesthesia, paresthesia</p>
<p><b>Frequency not reported</b>: VIIth nerve paralysis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Decreased hemoglobin, decreased platelet count</p>
<p><b>Uncommon</b> (0.1% to 1%): Decreased absolute neutrophil count, lymphadenopathy, decreased WBC count</p>
<p><b>Frequency not reported</b>: Anemia<sup>[Ref]</sup></p><p>Decreased hemoglobin (less than 10.1 g/dL in males; less than 9 g/dL in females), platelet count (less than 112 x 10[3]/mm3), and absolute neutrophil count (less than 0.8 x 10[3]/mm3) were reported in 3.4%, 2.1%, and 0.4% of patients, respectively.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Generalized pruritus</p>
<p><b>Uncommon</b> (0.1% to 1%): Dermatophytosis, pruritus, urticaria, hyperhidrosis, rash, alopecia, erythematous rash, generalized rash, acne, allergic pruritus, maculopapular rash, popular rash, pruritic rash</p>
<p><b>Frequency not reported</b>: Dermatitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p>
<p><b>Uncommon</b> (0.1% to 1%): Fungal infection, abscess, flushing, hot flush, chills, pyrexia, peripheral edema, grip strength decreased</p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion/injection-related side effects (including but not limited to phlebitis, injection/infusion-site pain, injection/infusion-site swelling, injection-site reaction, injection-site erythema, injection-site induration, infusion-related reaction), infusion site reactions (phlebitis)</p>
<p><b>Uncommon</b> (0.1% to 1%): Infusion-related reactions, infusion site pain<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Bradycardia</p>
<p><b>Frequency not reported</b>: Palpitations, tachycardia, hypertension<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Elevated hepatic transaminases</p>
<p><b>Frequency not reported</b>: Increased ALT, increased AST, increased GGT, abnormal liver function tests<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Insomnia, sleep disorder, anxiety, nightmare, irritability<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Drug hypersensitivity</p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Arthralgia, muscle spasms, back pain, limb discomfort, neck pain</p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Dehydration, inadequately controlled diabetes mellitus, hyperkalemia</p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Optic nerve disorders, blurred vision, vitreous floaters</p>
<p><b>Frequency not reported</b>: Asthenopia, visual impairment<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Respiratory tract infection, cough, nasal dryness, pulmonary congestion</p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Vulvovaginal mycotic infection, vulvovaginal candidiasis, abnormal urine odor, vulvovaginal pruritus</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Sivextro (tedizolid)." Cubist Pharmaceuticals Inc, Lexington, MA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Sivextro (tedizolid)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: oxazolidinone antibiotics</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Sivextro &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Sivextro Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Bacterial Infection</li>
<li>Skin and Structure Infection</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tedizolid: intravenous powder for injection, oral tablet</i></p><h3>General</h3><p>The most common side effects were nausea, headache, diarrhea, vomiting, and dizziness.  Median time to onset was 5 days.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Clostridioides difficile colitis, oral candidiasis, abdominal pain, constipation, abdominal discomfort, dry mouth, dyspepsia, upper abdominal pain, flatulence, gastroesophageal reflux disease, hematochezia, retching<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness, peripheral neuropathy</p><p><b>Uncommon</b> (0.1% to 1%): Somnolence, dysgeusia, tremor, hypoesthesia, paresthesia</p><p><b>Frequency not reported</b>: VIIth nerve paralysis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Decreased hemoglobin, decreased platelet count</p><p><b>Uncommon</b> (0.1% to 1%): Decreased absolute neutrophil count, lymphadenopathy, decreased WBC count</p><p><b>Frequency not reported</b>: Anemia<sup>[Ref]</sup></p><p>Decreased hemoglobin (less than 10.1 g/dL in males; less than 9 g/dL in females), platelet count (less than 112 x 10[3]/mm3), and absolute neutrophil count (less than 0.8 x 10[3]/mm3) were reported in 3.4%, 2.1%, and 0.4% of patients, respectively.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Generalized pruritus</p><p><b>Uncommon</b> (0.1% to 1%): Dermatophytosis, pruritus, urticaria, hyperhidrosis, rash, alopecia, erythematous rash, generalized rash, acne, allergic pruritus, maculopapular rash, popular rash, pruritic rash</p><p><b>Frequency not reported</b>: Dermatitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue</p><p><b>Uncommon</b> (0.1% to 1%): Fungal infection, abscess, flushing, hot flush, chills, pyrexia, peripheral edema, grip strength decreased</p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion/injection-related side effects (including but not limited to phlebitis, injection/infusion-site pain, injection/infusion-site swelling, injection-site reaction, injection-site erythema, injection-site induration, infusion-related reaction), infusion site reactions (phlebitis)</p><p><b>Uncommon</b> (0.1% to 1%): Infusion-related reactions, infusion site pain<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Bradycardia</p><p><b>Frequency not reported</b>: Palpitations, tachycardia, hypertension<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Elevated hepatic transaminases</p><p><b>Frequency not reported</b>: Increased ALT, increased AST, increased GGT, abnormal liver function tests<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Insomnia, sleep disorder, anxiety, nightmare, irritability<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Drug hypersensitivity</p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Arthralgia, muscle spasms, back pain, limb discomfort, neck pain</p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Dehydration, inadequately controlled diabetes mellitus, hyperkalemia</p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Optic nerve disorders, blurred vision, vitreous floaters</p><p><b>Frequency not reported</b>: Asthenopia, visual impairment<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Respiratory tract infection, cough, nasal dryness, pulmonary congestion</p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Vulvovaginal mycotic infection, vulvovaginal candidiasis, abnormal urine odor, vulvovaginal pruritus</p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Sivextro (tedizolid)." Cubist Pharmaceuticals Inc, Lexington, MA. </p><h2>More about Sivextro (tedizolid)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: oxazolidinone antibiotics</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Sivextro &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Sivextro Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Bacterial Infection</li>
<li>Skin and Structure Infection</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>